Biotech Research Compound Firm | Consumer & Wholesale Direct | Proprietary U.S. Domestic Lab | Massive MOM Growth | Ownership Interested in Equity Retention

Deal Pipe® presents a high-growth eCommerce and B2B Business within the Biotech Research Compound Industry that has rapidly established a strong market position through vertically coordinated production, disciplined digital marketing execution, and a proprietary backend infrastructure engineered for scale.

The company has achieved consistent daily order volume and accelerated revenue growth, driven by a model that tightly integrates supply chain control with sophisticated customer acquisition strategies across both direct-to-consumer and wholesale channels.

The company operates within a category experiencing significant structural tailwinds. The increasing demand for biotech research compounds reflects a broader shift toward precision-driven innovation in the biotech sector, with regulatory bodies continuing to move toward clearer, more standardized frameworks that support compliant development and commercialization. In parallel, consumer adoption is accelerating as buyers seek more targeted, science-backed solutions for performance, recovery, and wellness.

This dual momentum—regulatory maturation and expanding consumer demand—creates a favorable environment for sustained category growth and positions the business to capitalize on continued mainstream adoption.

Business Model

The business maintains a focused and expanding product catalog, currently consisting of 31 active SKUs with plans to scale toward 50 in the near term. Its production model combines international sourcing of raw materials with final-stage processing through a dedicated U.S. Domestic Lab partner that is dedicated to this business, enabling quality control while maintaining margin efficiency. Revenue is generated through a high-converting branded website on the DTC side, complemented by a rapidly growing wholesale segment managed through structured B2B accounts. This channel has already demonstrated meaningful traction, generating $300,000 in a single month and signaling strong demand for larger-volume purchasing.

The financial profile is particularly attractive, with an average order value of $220 and customer lifetime value exceeding $1,500. Customer acquisition costs remain highly efficient, ranging between $10 and $15, creating a substantial spread between acquisition spend and long-term revenue. This dynamic supports profitable scaling and provides buyers with a clear pathway to increased marketing investment without sacrificing margin discipline.

Digital Marketing & Traffic

The company’s marketing infrastructure is both robust and diversified, operating more than 20 advertising accounts across Meta, TikTok, and Google. This multi-account structure provides operational resilience, allowing campaigns to continue uninterrupted while enabling ongoing testing and scaling across platforms. It also reduces dependency on any single traffic source, a key risk mitigator from an acquisition standpoint.

Customer retention is driven through well-developed email and SMS systems, with automated flows and segmented campaigns designed to re-engage buyers based on purchase behavior. This lifecycle marketing approach enhances repeat purchase rates and maximizes lifetime value without increasing acquisition complexity. The business has also cultivated strong brand trust, supported by consistent 5-star customer feedback and a service model focused on rapid issue resolution.

Operations

Operationally, the company is built for efficiency and scale, currently processing approximately 250 orders per day, or roughly 1,750 orders per week. Fulfillment is handled through a 4,500 square foot facility spanning two units, equipped with automated labeling systems and commercial refrigeration to maintain inventory integrity. Orders placed before early afternoon are typically shipped the same day, reinforcing a strong customer experience.

Inventory management is disciplined, with approximately two months of stock typically maintained to support both retail and wholesale demand, though recent growth has tightened this buffer in certain periods. Current inventory sits at approximately $1.5 million at cost, providing sufficient capacity to meet ongoing demand while supporting near-term expansion.

The company’s proprietary backend system integrates inventory management, order routing, customer data, advertising analytics, and retention workflows into a single unified platform. This reduces manual oversight, increases operational visibility, and creates a scalable foundation that is difficult for competitors to replicate. Additional competitive advantages include established payment processing relationships, a large network of active ad accounts, and a semi-integrated production model that provides greater control over both supply and demand dynamics.

Customer support is handled by a trained team managing 50–70 inquiries per day across email and SMS, with a focus on rapid resolution and proactive customer care. This approach minimizes friction in the purchasing process and reinforces long-term customer retention.

Business Broker Takeaways

1. Highly Efficient Customer Economics. The company benefits from a rare combination of low acquisition costs and high lifetime value, creating a strong margin profile and enabling profitable, scalable growth.

2. Defensible Infrastructure & Operational Control. With a proprietary backend system, diversified marketing engine, and coordinated production model, the business has built meaningful barriers to entry that are not easily replicated by competitors.

3. Positioned Within a High-Growth Market Tailwind. The convergence of increasing regulatory clarity and rising consumer demand for precision-driven biotech products provides a powerful macro backdrop supporting continued expansion.

Growth Opportunities

The business is exceptionally well-positioned to scale through multiple clear and actionable growth levers. Expanding the wholesale segment represents a primary opportunity, as existing production capacity and infrastructure can support increased volume without requiring significant operational changes. The seller has identified this channel as a major focus over the next 12–24 months.

Additional opportunities include expanding the product catalog to capture evolving demand trends, optimizing packaging to improve margins and operational efficiency, and enhancing the website experience to drive higher conversion rates. The current systems, supply chain, and marketing infrastructure are already built to support this next phase of growth, allowing a buyer to scale revenue without rebuilding foundational components.

Summary

This business represents a rare opportunity to acquire a highly systemized, fast-growing operation positioned at the intersection of strong unit economics and favorable tailwinds in the Biotech industry. With scalable infrastructure, proven customer acquisition strategies, and expanding B2B demand, the company offers immediate cash flow alongside significant upside potential. A buyer steps into a well-run, defensible platform with clear pathways to accelerate growth and capture increasing market demand.

Code Name: Project Scooby Snacks

This Biotech Company is Represented by:

Deal Pipe

Biotech Business Brokers

WC 3983